Tech Company Financing Transactions

SynapDx Funding Round

The Kraft Group participated in a funding round for SynapDx. The financing round was announced on 3/27/2013.

Transaction Overview

Company Name
Announced On
3/27/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Proceeds Purpose
The funding will support the ongoing clinical development of SynapDx's breakthrough blood-based autism spectrum disorder (ASD) diagnostic test, designed to help clinicians identify children with autism earlier than they do today.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4 Hartwell Pl.
Lexington, MA 02421
USA
Email Address
Overview
SynapDx was formed to develop and commercialize blood-based diagnostic tests for the early detection of autism.
Profile
SynapDx LinkedIn Company Profile
Social Media
SynapDx Company Twitter Account
Company News
SynapDx News
Facebook
SynapDx on Facebook
YouTube
SynapDx on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stanley Lapidus
  Stanley Lapidus LinkedIn Profile  Stanley Lapidus Twitter Account  Stanley Lapidus News  Stanley Lapidus on Facebook
Chief Financial Officer
Bill Romeo
  Bill Romeo LinkedIn Profile  Bill Romeo Twitter Account  Bill Romeo News  Bill Romeo on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/27/2013: EmiSense Technologies venture capital transaction
Next: 3/27/2013: Demandbase venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary